Long-Term Corticosteroids Not Necessary After Kidney Transplant
No increased risk of allograft failure in patients who discontinued treatment The use of long-term...
Read More
Transplantation
Organ Donation After Cardiac Death Has Unique Challenges
Resumption of cardiac activity following life support withdrawal not unusual Even in 2021,...
Read More
Frailty Tied to Gender Gap in Liver Transplant Wait-List Mortality
Women with cirrhosis displayed worse frailty scores despite similar liver disease severity Women...
Read More
Oxygen Delivered During Donor Kidney Preservation is Easy, Safe, Adds Minimal Cost
Also associated with improved outcomes Supplemental oxygen delivered along with hypothermic...
Read More
Heart Transplant: UNOS Policy Cut Wait Times, Mortality, but Post-transplant Survival Increased
Experts call for reconsideration of 2018 policy change Changes in the U.S. United Network for...
Read More
Considering Lung Transplant Frailty
The goal of lung transplantation is to improve quality of life (QOL) and extend survival for...
Read More
Liver Transplant Outcomes with ’Marginal’ and Benchmark Allografts Similar
Study findings encourage aggressive use of liver allografts Outcomes among liver transplant...
Read More
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read MoreSex Inequities in Liver Transplant Result Longer Wait Times, Death for Women
Mitigating geographic disparities not enough Sex-based inequities in access to liver transplants won’t necessarily be solved by just enacting policies designed to mitigate geographic disparities in liver allocations.In...
Read More
Covid-19: High Mortality Seen in Heart Transplant Patients
Small series points to complex issues for HT patients with Covid-19 Over an 8-week period...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read More- 1
- 2